Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

ANTIVORIFUNGOL:Strategy of Antifungal Use in Oncohematological Neutropenic Patients. Use of Voriconazole as Early Treatment.

NCT00386802 is registered in ClinicalTrials.gov with PETHEMA Foundation as lead sponsor.

NCT NCT00386802
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00386802 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
ANTIVORIFUNGOL:Strategy of Antifungal Use in Oncohematological Neutropenic Patients. Use of Voriconazole as Early Treatment.
Lead sponsor
PETHEMA Foundation
Phase
Phase 4
Overall status
Completed
Start date
August 31, 2006
Completion date
January 31, 2009
Enrollment
115 (estimated)
Sites
13

Conditions

As the registry lists them; a condition with its own page is linked.

invader fungal infection